<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33452693</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-896X</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Protein science : a publication of the Protein Society</Title><ISOAbbreviation>Protein Sci</ISOAbbreviation></Journal><ArticleTitle>Interplay between tau and &#x3b1;-synuclein liquid-liquid phase separation.</ArticleTitle><Pagination><StartPage>1326</StartPage><EndPage>1336</EndPage><MedlinePgn>1326-1336</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pro.4025</ELocationID><Abstract><AbstractText>In Parkinson's disease with dementia, up to 50% of patients develop a high number of tau-containing neurofibrillary tangles. Tau-based pathologies may thus act synergistically with the &#x3b1;-synuclein pathology to confer a worse prognosis. A better understanding of the relationship between the two distinct pathologies is therefore required. Liquid-liquid phase separation (LLPS) of proteins has recently been shown to be important for protein aggregation involved in amyotrophic lateral sclerosis, whereas tau phase separation has been linked to Alzheimer's disease. We therefore investigated the interaction of &#x3b1;-synuclein with tau and its consequences on tau LLPS. We find &#x3b1;-synuclein to have a low propensity for both, self-coacervation and RNA-mediated LLPS at pH&#xa0;7.4. However, full-length but not carboxy-terminally truncated &#x3b1;-synuclein efficiently partitions into tau/RNA droplets. We further demonstrate that Cdk2-phosphorylation promotes the concentration of tau into RNA-induced droplets, but at the same time decreases the amount of &#x3b1;-synuclein inside the droplets. NMR spectroscopy reveals that the interaction of the carboxy-terminal domain of &#x3b1;-synuclein with the proline-rich region P2 of tau is required for the recruitment of &#x3b1;-synuclein into tau droplets. The combined data suggest that the concentration of &#x3b1;-synuclein into tau-associated condensates can contribute to synergistic aSyn/tau pathologies.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Protein Science published by Wiley Periodicals LLC. on behalf of The Protein Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Siegert</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rankovic</LastName><ForeName>Marija</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department for NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Favretto</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ukmar-Godec</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stroh&#xe4;ker</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department for NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zweckstetter</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2536-6581</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Protein Sci</MedlineTA><NlmUniqueID>9211750</NlmUniqueID><ISSNLinking>0961-8368</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C054369">MAPT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497604">SNCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LLPS</Keyword><Keyword MajorTopicYN="N">phosphorylation</Keyword><Keyword MajorTopicYN="N">tau</Keyword><Keyword MajorTopicYN="N">truncation</Keyword><Keyword MajorTopicYN="N">&#x3b1;-synuclein</Keyword></KeywordList><CoiStatement>The authors declare no potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33452693</ArticleId><ArticleId IdType="pmc">PMC8197422</ArticleId><ArticleId IdType="doi">10.1002/pro.4025</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yan X, Uronen RL, Huttunen HJ (2020) The interaction of alpha&#x2010;synuclein and tau: A molecular conspiracy in neurodegeneration? Semin Cell Dev Biol 99:55&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">29738880</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, Lee VM, Trojanowski JQ (2013) Parkinson's disease dementia: Convergence of alpha&#x2010;synuclein, tau and amyloid&#x2010;beta pathologies. Nat Rev Neurosci 14:626&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4017235</ArticleId><ArticleId IdType="pubmed">23900411</ArticleId></ArticleIdList></Reference><Reference><Citation>Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM (2003) Initiation and synergistic fibrillization of tau and alpha&#x2010;synuclein. Science 300:636&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">12714745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhasne K, Sebastian S, Jain N, Mukhopadhyay S (2018) Synergistic amyloid switch triggered by early heterotypic oligomerization of intrinsically disordered alpha&#x2010;synuclein and tau. J Mol Biol 430:2508&#x2013;2520.</Citation><ArticleIdList><ArticleId IdType="pubmed">29704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Badiola N, de Oliveira RM, Herrera F, Guardia&#x2010;Laguarta C, Goncalves SA, Pera M, Suarez&#x2010;Calvet M, Clarimon J, Outeiro TF, Lleo A (2011) Tau enhances alpha&#x2010;synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS One 6:e26609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200341</ArticleId><ArticleId IdType="pubmed">22039514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta U, Guerrero&#x2010;Munoz MJ, Castillo&#x2010;Carranza DL, Lasagna&#x2010;Reeves CA, Gerson JE, Paulucci&#x2010;Holthauzen AA, Krishnamurthy S, Farhed M, Jackson GR, Kayed R (2015) Pathological interface between oligomeric alpha&#x2010;synuclein and tau in synucleinopathies. Biol Psychiatry 78:672&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">25676491</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito A, Dohm CP, Kermer P, Bahr M, Wouters FS (2007) Alpha&#x2010;synuclein and its disease&#x2010;related mutants interact differentially with the microtubule protein tau and associate with the Actin cytoskeleton. Neurobiol Dis 26:521&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">17408955</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi L, Ghidoni R, Paterlini A, Nicosia F, Alberici AC, Signorini S, Barbiero L, Binetti G (2005) Interaction between tau and alpha&#x2010;synuclein proteins is impaired in the presence of P301L tau mutation. Exp Cell Res 308:78&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">15904919</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen PH, Hager H, Nielsen MS, Hojrup P, Gliemann J, Jakes R (1999) Alpha&#x2010;synuclein binds to tau and stimulates the protein kinase A&#x2010;catalyzed tau phosphorylation of serine residues 262 and 356. J Biol Chem 274:25481&#x2013;25489.</Citation><ArticleIdList><ArticleId IdType="pubmed">10464279</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy B, Jackson GR (2014) Interactions between tau and alpha&#x2010;synuclein augment neurotoxicity in a drosophila model of Parkinson's disease. Hum Mol Genet 23:3008&#x2013;3023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4014195</ArticleId><ArticleId IdType="pubmed">24430504</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VM (2013) Distinct alpha&#x2010;synuclein strains differentially promote tau inclusions in neurons. Cell 154:103&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820001</ArticleId><ArticleId IdType="pubmed">23827677</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong PA, Forman&#x2010;Kay JD (2016) Liquid&#x2010;liquid phase separation in cellular signaling systems. Curr Opin Struct Biol 41:180&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">27552079</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman AA, Weber CA, Julicher F (2014) Liquid&#x2010;liquid phase separation in biology. Annu Rev Cell Dev Biol 30:39&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">25288112</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A, Altmeyer M (2016) Phase separation: Linking cellular compartmentalization to disease. Trends Cell Biol 26:547&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pubmed">27051975</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, Stoynov S, Mahamid J, Saha S, Franzmann TM, Pozniakovski A, Poser I, Maghelli N, Royer LA, Weigert M, Myers EW, Grill S, Drechsel D, Hyman AA, Alberti S (2015) A liquid&#x2010;to&#x2010;solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162:1066&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: From genes to mechanism. Nature 539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z, Ryan VH, Janke AM, Burke KA, Rhoads SN, Zerze GH, O'Meally R, Dignon GL, Conicella AE, Zheng W, Best RB, Cole RN, Mittal J, Shewmaker F, Fawzi NL (2017) Phosphorylation of the FUS low&#x2010;complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J 36:2951&#x2013;2967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Kovacs D, Konijnenberg A, Timmerman E, Volkov A, Guharoy M, De Decker M, Jaspers T, Ryan VH, Janke AM, Baatsen P, Vercruysse T, Kolaitis RM, Daelemans D, Taylor JP, Kedersha N, Anderson P, Impens F, Sobott F, Schymkowitz J, Rousseau F, Fawzi NL, Robberecht W, Van Damme P, Tompa P, Van Den Bosch L (2017) Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol Cell 65:1044&#x2013;1055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, Mittag T, Taylor JP (2015) Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163:123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Zerze GH, Mittal J, Fawzi NL (2016) ALS mutations disrupt phase separation mediated by alpha&#x2010;helical structure in the TDP&#x2010;43 low&#x2010;complexity C&#x2010;terminal domain. Structure 24:1537&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambadipudi S, Biernat J, Riedel D, Mandelkow E, Zweckstetter M (2017) Liquid&#x2010;liquid phase separation of the microtubule&#x2010;binding repeats of the Alzheimer&#x2010;related protein tau. Nat Commun 8:275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5561136</ArticleId><ArticleId IdType="pubmed">28819146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Lin Y, Eschmann NA, Zhou H, Rauch JN, Hernandez I, Guzman E, Kosik KS, Han S (2017) RNA stores tau reversibly in complex coacervates. PLoS Biol 15:e2002183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5500003</ArticleId><ArticleId IdType="pubmed">28683104</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegmann S, Eftekharzadeh B, Tepper K, Zoltowska KM, Bennett RE, Dujardin S, Laskowski PR, MacKenzie D, Kamath T, Commins C, Vanderburg C, Roe AD, Fan Z, Molliex AM, Hernandez&#x2010;Vega A, Muller D, Hyman AA, Mandelkow E, Taylor JP, Hyman BT (2018) Tau protein liquid&#x2010;liquid phase separation can initiate tau aggregation. EMBO J 37:e98049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5881631</ArticleId><ArticleId IdType="pubmed">29472250</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano A, Flores D, Kadavath H, Biernat J, Mandelkow E, Zweckstetter M (2021) Disease&#x2010;associated tau phosphorylation hinders tubulin assembly within tau condensates. Angew Chem Int Ed Engl 60:726&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7839466</ArticleId><ArticleId IdType="pubmed">33017094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreon JC, Jain A, Choi KJ, Tsoi PS, MacKenzie KR, Jung SY, Ferreon AC (2018) Acetylation disfavors tau phase separation. Int J Mol Sci 19:1360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983838</ArticleId><ArticleId IdType="pubmed">29734651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukmar&#x2010;Godec T, Hutten S, Grieshop MP, Rezaei&#x2010;Ghaleh N, Cima&#x2010;Omori MS, Biernat J, Mandelkow E, Soding J, Dormann D, Zweckstetter M (2019) Lysine/RNA&#x2010;interactions drive and regulate biomolecular condensation. Nat Commun 10:2909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6606616</ArticleId><ArticleId IdType="pubmed">31266957</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez&#x2010;Vega A, Braun M, Scharrel L, Jahnel M, Wegmann S, Hyman BT, Alberti S, Diez S, Hyman AA (2017) Local nucleation of microtubule bundles through tubulin concentration into a condensed tau phase. Cell Rep 20:2304&#x2013;2312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5828996</ArticleId><ArticleId IdType="pubmed">28877466</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan R, Lam AJ, Tan T, Han J, Nowakowski DW, Vershinin M, Simo S, Ori&#x2010;McKenney KM, McKenney RJ (2019) Microtubules gate tau condensation to spatially regulate microtubule functions. Nat Cell Biol 21:1078&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6748660</ArticleId><ArticleId IdType="pubmed">31481790</ArticleId></ArticleIdList></Reference><Reference><Citation>Siahaan V, Krattenmacher J, Hyman AA, Diez S, Hernandez&#x2010;Vega A, Lansky Z, Braun M (2019) Kinetically distinct phases of tau on microtubules regulate kinesin motors and severing enzymes. Nat Cell Biol 21:1086&#x2013;1092.</Citation><ArticleIdList><ArticleId IdType="pubmed">31481789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray S, Singh N, Kumar R, Patel K, Pandey S, Datta D, Mahato J, Panigrahi R, Navalkar A, Mehra S, Gadhe L, Chatterjee D, Sawner AS, Maiti S, Bhatia S, Gerez JA, Chowdhury A, Kumar A, Padinhaeeri R, Riek R, Krishnamoorthy G, Maji SK (2020) &#x3b1;&#x2010;Synuclein aggregation nucleates through liquid&#x2013;liquid phase separation. Nat Chem 12:705&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">32514159</ArticleId></ArticleIdList></Reference><Reference><Citation>Oueslati A, Fournier M, Lashuel HA (2010) Role of post&#x2010;translational modifications in modulating the structure, function and toxicity of alpha&#x2010;synuclein: Implications for Parkinson's disease pathogenesis and therapies. Prog Brain Res 183:115&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">20696318</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Kang SS, Liu X, Ahn EH, Zhang Z, He L, Iuvone PM, Duong DM, Seyfried NT, Benskey MJ, Manfredsson FP, Jin L, Sun YE, Wang JZ, Ye K (2017) Asparagine endopeptidase cleaves alpha&#x2010;synuclein and mediates pathologic activities in Parkinson's disease. Nat Struct Mol Biol 24:632&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5871868</ArticleId><ArticleId IdType="pubmed">28671665</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong PA, Vernon RM, Forman&#x2010;Kay JD (2018) RGG/RG motif regions in RNA binding and phase separation. J Mol Biol 430:4650&#x2013;4665.</Citation><ArticleIdList><ArticleId IdType="pubmed">29913160</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden C, Gladfelter AS (2020) RNA contributions to the form and function of biomolecular condensates. Nat Rev Mol Cell Biol, 10, 2020 Jul 6. 10.1038/s41580-020-0264-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0264-6</ArticleId><ArticleId IdType="pmc">PMC7785677</ArticleId><ArticleId IdType="pubmed">32632317</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:5&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">26631930</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz A, Verma M, Wolozin B (2019) The pathophysiology of tau and stress granules in disease. Adv Exp Med Biol 1184:359&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">32096049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Zhang S, Ma X, Jia C, Liu Z, Huang C, Liu C, Li D (2020) Structural basis of the interplay between alpha&#x2010;synuclein and tau in regulating pathological amyloid aggregation. J Biol Chem 295:7470&#x2013;7480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247300</ArticleId><ArticleId IdType="pubmed">32291284</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasari AKR, Kayed R, Wi S, Lim KH (2019) Tau interacts with the C&#x2010;terminal region of alpha&#x2010;synuclein, promoting formation of toxic aggregates with distinct molecular conformations. Biochemistry 58:2814&#x2013;2821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6754703</ArticleId><ArticleId IdType="pubmed">31132261</ArticleId></ArticleIdList></Reference><Reference><Citation>Waxman EA, Giasson BI (2011) Induction of intracellular tau aggregation is promoted by alpha&#x2010;synuclein seeds and provides novel insights into the hyperphosphorylation of tau. J Neurosci 31:7604&#x2013;7618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3122484</ArticleId><ArticleId IdType="pubmed">21613474</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyko S, Qi X, Chen TH, Surewicz K, Surewicz WK (2019) Liquid&#x2010;liquid phase separation of tau protein: The crucial role of electrostatic interactions. J Biol Chem 294:11054&#x2013;11059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6643045</ArticleId><ArticleId IdType="pubmed">31097543</ArticleId></ArticleIdList></Reference><Reference><Citation>Banani SF, Rice AM, Peeples WB, Lin Y, Jain S, Parker R, Rosen MK (2016) Compositional control of phase&#x2010;separated cellular bodies. Cell 166:651&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4967043</ArticleId><ArticleId IdType="pubmed">27374333</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalbe M, Kadavath H, Biernat J, Ozenne V, Blackledge M, Mandelkow E, Zweckstetter M (2015) Structural impact of tau phosphorylation at threonine 231. Structure 23:1448&#x2013;1458.</Citation><ArticleIdList><ArticleId IdType="pubmed">26165593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen LB, Reimer L, Ferreira N, Betzer C, Jensen PH (2016) Protein partners of alpha&#x2010;synuclein in health and disease. Brain Pathol 26:389&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8029326</ArticleId><ArticleId IdType="pubmed">26940507</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustke N, Trinczek B, Biernat J, Mandelkow EM, Mandelkow E (1994) Domains of tau protein and interactions with microtubules. Biochemistry 33:9511&#x2013;9522.</Citation><ArticleIdList><ArticleId IdType="pubmed">8068626</ArticleId></ArticleIdList></Reference><Reference><Citation>Amniai L, Barbier P, Sillen A, Wieruszeski JM, Peyrot V, Lippens G, Landrieu I (2009) Alzheimer disease specific phosphoepitopes of tau interfere with assembly of tubulin but not binding to microtubules. FASEB J 23:1146&#x2013;1152.</Citation><ArticleIdList><ArticleId IdType="pubmed">19074508</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagoz GE, Duarte AM, Akoury E, Ippel H, Biernat J, Moran Luengo T, Radli M, Didenko T, Nordhues BA, Veprintsev DB, Dickey CA, Mandelkow E, Zweckstetter M, Boelens R, Madl T, Rudiger SG (2014) Hsp90&#x2010;tau complex reveals molecular basis for specificity in chaperone action. Cell 156:963&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4263503</ArticleId><ArticleId IdType="pubmed">24581495</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyer W, Antony T, Cherny D, Heim G, Jovin TM, Subramaniam V (2002) Dependence of alpha&#x2010;synuclein aggregate morphology on solution conditions. J Mol Biol 322:383&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pubmed">12217698</ArticleId></ArticleIdList></Reference><Reference><Citation>Strohaker T, Jung BC, Liou SH, Fernandez CO, Riedel D, Becker S, Halliday GM, Bennati M, Kim WS, Lee SJ, Zweckstetter M (2019) Structural heterogeneity of alpha&#x2010;synuclein fibrils amplified from patient brain extracts. Nat Commun 10:5535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6893031</ArticleId><ArticleId IdType="pubmed">31797870</ArticleId></ArticleIdList></Reference><Reference><Citation>Schanda P, Kupce E, Brutscher B (2005) SOFAST&#x2010;HMQC experiments for recording two&#x2010;dimensional heteronuclear correlation spectra of proteins within a few seconds. J Biomol NMR 33:199&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">16341750</ArticleId></ArticleIdList></Reference><Reference><Citation>Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, Laue ED (2005) The CCPN data model for NMR spectroscopy: Development of a software pipeline. Proteins 59:687&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">15815974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermel W, Bertini I, Felli IC, Lee YM, Luchinat C, Pierattelli R (2006) Protonless NMR experiments for sequence&#x2010;specific assignment of backbone nuclei in unfolded proteins. J Am Chem Soc 128:3918&#x2013;3919.</Citation><ArticleIdList><ArticleId IdType="pubmed">16551093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoncini CW, Jung YS, Fernandez CO, Hoyer W, Griesinger C, Jovin TM, Zweckstetter M (2005) Release of long&#x2010;range tertiary interactions potentiates aggregation of natively unstructured alpha&#x2010;synuclein. Proc Natl Acad Sci USA 102:1430&#x2013;1435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC547830</ArticleId><ArticleId IdType="pubmed">15671169</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan RL, Durr UH, Bibow S, Biernat J, Mandelkow E, Zweckstetter M (2010) Automatic assignment of the intrinsically disordered protein tau with 441&#x2010;residues. J Am Chem Soc 132:11906&#x2013;11907.</Citation><ArticleIdList><ArticleId IdType="pubmed">20687558</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukrasch MD, Bibow S, Korukottu J, Jeganathan S, Biernat J, Griesinger C, Mandelkow E, Zweckstetter M (2009) Structural polymorphism of 441&#x2010;residue tau at single residue resolution. PLoS Biol 7:e34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2642882</ArticleId><ArticleId IdType="pubmed">19226187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukmar&#x2010;Godec T, Fang P, Ibanez de Opakua A, Henneberg F, Godec A, Pan KT, Cima&#x2010;Omori MS, Chari A, Mandelkow E, Urlaub H, Zweckstetter M (2020) Proteasomal degradation of the intrinsically disordered protein tau at single&#x2010;residue resolution. Sci Adv 6:eaba3916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439447</ArticleId><ArticleId IdType="pubmed">32832664</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukrasch MD, von Bergen M, Biernat J, Fischer D, Griesinger C, Mandelkow E, Zweckstetter M (2007) The "jaws" of the tau&#x2010;microtubule interaction. J Biol Chem 282:12230&#x2013;12239.</Citation><ArticleIdList><ArticleId IdType="pubmed">17307736</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>